查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1876483

全EXOME定序市场：全球产业分析、规模、份额、成长、趋势与预测（2025-2032）

Whole Exome Sequencing Market: Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2025 - 2032
出版日期: | 出版商: Persistence Market Research | 英文 180 Pages | 商品交期: 2-5个工作天内

价格
简介目录

Persistence Market Research近期发布了一份关于全球全EXOME序（WES）市场的综合报告。该报告深入分析了市场结构，并对关键市场动态进行了全面评估，包括驱动因素、趋势、机会和挑战。该研究报告提供了独家数据和统计信息，展现了2025年至2032年全球全EXOME组测序市场的预期增长轨迹。

主要发现：

  • 全EXOME定序市场规模（2025年）：21.735亿美元
  • 预计市场价值（2032年）：68.796亿美元
  • 全球市场成长率（2025年至2032年复合年增长率）：17.9%

全EXOME市场—研究范围：

全EXOME定序在遗传疾病研究中发挥关键作用，为疾病机制和潜在治疗方法提供了宝贵的见解。 WES市场面向医院、研究机构、实验室和临床机构，提供各种定序服务和解决方案。市场成长的驱动力包括定序技术的进步、成本的下降以及对精准医疗、基因检测和个人化医疗日益增长的需求。

市场成长驱动因素：

全球全EXOME定序市场受多种关键因素驱动，包括遗传疾病盛行率的上升和对个人化医疗日益增长的需求。基因组研究的日益重视、新一代定序（NGS）等定序技术的进步以及定序成本的下降也推动了市场扩张。此外，全外显子定序在癌症研究、罕见疾病诊断和药物研发的应用也促进了EXOME序服务的普及。同时，政府投入的增加和基因检测平台的扩展也为市场参与者带来了新的机会。

市场限制：

儘管全EXOME定序市场前景广阔，但仍面临高成本、伦理问题和监管障碍等挑战。数据分析和结果解读的复杂性可能成为其广泛应用的重大障碍，尤其是在资源匮乏的地区。此外，资料隐私、病患知情同意以及基因检测的伦理挑战等问题也持续困扰着相关人员。将基因组数据整合到临床实践中也存在许多挑战，需要医疗服务提供者、政策制定者和研究人员之间的合作。

市场机会：

由于人工智慧 (AI) 在基因组数据分析中的应用、罕见遗传疾病研究的拓展以及对个人化治疗策略需求的日益增长，全EXOME组定序市场展现出巨大的成长潜力。可携式、低成本定序仪和就地检验平台的开发有望为市场参与者开闢新的道路。此外，对伴随诊断的日益重视以及基于基因组数据的标靶治疗的开发，预计也将推动全EXOME序服务的需求。

本报告解答的关键问题：

  • 推动全球全EXOME显子定序市场成长的关键因素有哪些？
  • 定序技术的进步如何影响全EXOME定序的应用？
  • WES在医疗和研究领域的主要应用有哪些？
  • 哪些公司是全EXOME定序市场的主要企业贡献者？它们正在采取哪些策略来维持其市场地位？
  • 全球全EXOME定序市场有哪些新兴趋势与未来前景？

目录

第一章执行摘要

第二章 市场概览

  • 市场范围和定义
  • 市场动态
    • 司机
    • 抑制因素
    • 机会
    • 主要趋势
  • 宏观经济因素
    • 全球产业展望
    • 全球GDP成长预测
  • 新冠疫情影响分析
  • 预测因子：相关性和影响

第三章 加值见解

  • 产品采纳分析
  • 监管状态
  • 波特五力分析
  • PESTLE分析
  • 主要企业的促销策略

第四章 定价分析，2025年

  • 主要亮点
  • 影响产品价格的关键因素
  • 产品价格分析
  • 区域价格和产品偏好

5. 全球全EXOME定序市场展望

  • 主要亮点
    • 市场规模预测
    • 市场规模和年成长率
    • 绝对商机
  • 市场规模分析与预测
    • 2019-2024年历史市场规模与交易量分析
    • 市场规模及销售分析及预测（2025-2032年）
  • 全球全EXOME定序市场展望：产品
    • 引言/主要发现
    • 按产品分類的历史市场规模与销售分析（2019-2024 年）
    • 市场规模及销售分析及预测（依产品划分），2025-2032年
      • 装置
      • 消耗品
      • 软体和服务
    • 市场吸引力分析：产品
  • 全球全EXOME市场展望：应用
    • 引言/主要发现
    • 按应用领域分類的历史市场规模，2019-2024 年
    • 按应用领域分類的市场规模分析与预测（2025-2032年）
      • 药物发现与开发
      • 临床诊断
      • 个人化医疗
      • 其他的
    • 市场吸引力分析：应用
  • 全球全EXOME市场展望：技术
    • 引言/主要发现
    • 按技术分類的历史市场规模，2019-2024 年
    • 依技术分類的市场规模分析及预测（2025-2032 年）
      • ION半导体序列
      • 合成定序
      • 其他的
    • 市场吸引力分析：技术
  • 全球全EXOME市场展望：终端用户
    • 引言/主要发现
    • 按最终用户分類的历史市场规模，2019-2024 年
    • 依最终用户分類的市场规模分析及预测（2025-2032 年）
      • 医院和诊断检查室
      • 製药和生物技术公司
      • 合约研究组织（CRO）
      • 学术研究机构
      • 其他的
    • 市场吸引力分析：最终用户

6. 全球全EXOME市场区域展望

  • 主要亮点
  • 按地区分類的历史市场规模分析（2019-2024 年）
  • 市场规模分析及预测（依地区划分，2025-2032年）
    • 北美洲
    • 欧洲
    • 东亚
    • 南亚和大洋洲
    • 拉丁美洲
    • 中东和非洲
  • 市场吸引力分析：区域

7. 北美全EXOME定序市场展望

8. 欧洲全EXOME定序市场展望

9. 东亚全EXOME定序市场展望

10. 南亚和大洋洲全EXOME定序市场展望

11. 拉丁美洲全EXOME定序市场展望

12. 中东和非洲全外EXOME市场展望

第十三章 竞争格局

  • 2025年市占率分析
  • 市场结构
    • 市场竞争加剧地图
    • 竞争对手仪錶板
  • 公司简介（详情：概述、财务状况、策略、近期发展）
    • CD Genomics
    • Eurofins Genomics
    • GENEWIZ（Azenta Life Sciences）
    • Illumina, Inc.
    • Integrated DNA Technologies, Inc.
    • Blueprint Genetics Oy
    • Caris Life Sciences
    • MedGenome
    • Psomagen
    • 3billion, Inc.
    • BGI
    • Mapmygenome
    • Almac Group
    • CeGaT GmbH
    • Novogene Co., Ltd
    • ONEOMICS
    • Celemics, Inc.
    • Dreamgenics, SL
    • Gene by Gene, Ltd
    • VERITAS INTERCONTINENTAL
    • Laboratory Corporation of America（R）Holdings
    • Revvity
    • Thermo Fisher Scientific Inc.

第十四章附录

  • 调查方法
  • 调查先决条件
  • 首字母缩写和简称
简介目录
Product Code: PMRREP3193

Persistence Market Research has recently released a comprehensive report on the worldwide market for whole exome sequencing (WES). The report offers a thorough assessment of crucial market dynamics, including drivers, trends, opportunities, and challenges, providing detailed insights into the market structure. This research publication presents exclusive data and statistics outlining the anticipated growth trajectory of the global whole exome sequencing market from 2025 to 2032.

Key Insights:

  • Whole Exome Sequencing Market Size (2025E): USD 2,173.5 Million
  • Projected Market Value (2032F): USD 6,879.6 Million
  • Global Market Growth Rate (CAGR 2025 to 2032): 17.9%

Whole Exome Sequencing Market - Report Scope:

Whole exome sequencing plays a crucial role in the study of genetic diseases, providing valuable insights into disease mechanisms and potential treatments. The WES market caters to hospitals, research institutions, academic laboratories, and clinical settings, offering a range of sequencing services and solutions. Market growth is driven by advancements in sequencing technologies, decreasing costs, and an increasing demand for precision medicine, genetic testing, and personalized healthcare.

Market Growth Drivers:

The global whole exome sequencing market is propelled by several key factors, including the rising prevalence of genetic disorders and the growing demand for personalized medicine. The increasing focus on genomic research, advancements in sequencing technologies like next-generation sequencing (NGS), and decreasing costs of sequencing are further fueling market expansion. Additionally, the use of WES in cancer research, rare disease diagnosis, and drug development contributes to the growing adoption of exome sequencing services. Moreover, the increased government funding and the expansion of genetic testing platforms provide new opportunities for market players.

Market Restraints:

Despite promising growth prospects, the whole exome sequencing market faces challenges related to high costs, ethical concerns, and regulatory hurdles. The complexity of data analysis and the interpretation of results can be significant barriers to widespread adoption, particularly in resource-limited settings. Additionally, issues around data privacy, patient consent, and the ethical implications of genetic testing present ongoing challenges for stakeholders. The market also faces challenges in terms of the integration of genomic data into clinical practice, requiring collaboration among healthcare providers, policymakers, and researchers.

Market Opportunities:

The whole exome sequencing market presents significant growth opportunities driven by the integration of artificial intelligence (AI) in genomic data analysis, expanding research in rare genetic diseases, and the growing demand for personalized treatment strategies. The development of portable and cost-effective sequencing devices and platforms for point-of-care testing is expected to create new avenues for market players. Furthermore, the increasing focus on companion diagnostics and the development of targeted therapies based on genomic data will drive demand for whole exome sequencing services.

Key Questions Answered in the Report:

  • What are the primary factors driving the growth of the whole exome sequencing market globally?
  • How are advancements in sequencing technologies shaping the adoption of whole exome sequencing?
  • What are the major applications of WES across healthcare and research settings?
  • Who are the key players contributing to the whole exome sequencing market, and what strategies are they employing to maintain market relevance?
  • What are the emerging trends and future prospects in the global whole exome sequencing market?

Competitive Intelligence and Business Strategy:

Leading players in the global whole exome sequencing market, including Illumina, Thermo Fisher Scientific, and Agilent Technologies, focus on innovation, product differentiation, and strategic collaborations to maintain a competitive edge. These companies invest in research and development to advance sequencing technologies, improve accuracy, and lower sequencing costs. Collaborations with academic institutions, healthcare providers, and biotechnology companies facilitate market access and promote the adoption of WES technologies. Additionally, the emphasis on personalized medicine and targeted therapies drives further research and investment into the WES market.

Key Companies Profiled:

  • CD Genomics
  • Eurofins Genomics
  • GENEWIZ (Azenta Life Sciences)
  • Illumina, Inc.
  • Integrated DNA Technologies, Inc.
  • Blueprint Genetics Oy
  • Caris Life Sciences
  • MedGenome
  • Psomagen
  • 3billion, Inc.
  • BGI
  • Mapmygenome
  • Almac Group
  • CeGaT GmbH
  • Novogene Co., Ltd
  • ONEOMICS
  • Celemics, Inc.
  • Dreamgenics, S.L.
  • Gene by Gene, Ltd
  • VERITAS INTERCONTINENTAL
  • Laboratory Corporation of America(R) Holdings
  • Revvity
  • Thermo Fisher Scientific Inc.

Whole Exome Sequencing Market Research Segmentation:

The whole exome sequencing market encompasses a diverse range of products, technologies, applications, and end-user segments, addressing various healthcare needs and research fields.

By Product:

  • Instruments
  • Consumables
  • Software and Services

By Application:

  • Drug Discovery & Development
  • Clinical Diagnostics
  • Personalized Medicines
  • Others

By Technology:

  • ION Semiconductor Sequencing
  • Sequencing by Synthesis
  • Others

By End-User:

  • Hospitals & Diagnostic Laboratories
  • Pharma & Biotech Companies
  • Contract Research Organizations (CROs)
  • Academic and Research Institutes
  • Others

By Region:

  • North America
  • Europe
  • East Asia
  • South Asia and Oceania
  • Latin America
  • Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Whole Exome Sequencing Market Snapshot, 2025 and 2032
  • 1.2. Market Opportunity Assessment, 2025-2032, US$ Mn
  • 1.3. Key Market Trends
  • 1.4. Future Market Projections
  • 1.5. Premium Market Insights
  • 1.6. Industry Developments and Key Market Events
  • 1.7. PMR Analysis and Recommendations

2. Market Overview

  • 2.1. Market Scope and Definition
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Opportunity
    • 2.2.4. Key Trends
  • 2.3. Macro-Economic Factors
    • 2.3.1. Global Sectorial Outlook
    • 2.3.2. Global GDP Growth Outlook
  • 2.4. COVID-19 Impact Analysis
  • 2.5. Forecast Factors - Relevance and Impact

3. Value Added Insights

  • 3.1. Product Adoption Analysis
  • 3.2. Regulatory Landscape
  • 3.3. Porter's Five Forces Analysis
  • 3.4. PESTLE Analysis
  • 3.5. Promotional Strategies, By Key Players

4. Price Analysis, 2025A

  • 4.1. Key Highlights
  • 4.2. Key Factors Impacting Product Prices
  • 4.3. Pricing Analysis, By Product
  • 4.4. Regional Prices and Product Preferences

5. Global Whole Exome Sequencing Market Outlook

  • 5.1. Key Highlights
    • 5.1.1. Market Volume (Units) Projections
    • 5.1.2. Market Size (US$ Mn) and Y-o-Y Growth
    • 5.1.3. Absolute $ Opportunity
  • 5.2. Market Size (US$ Mn) Analysis and Forecast
    • 5.2.1. Historical Market Size (US$ Mn) and Volume (Units) Analysis, 2019-2024
    • 5.2.2. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, 2025-2032
  • 5.3. Global Whole Exome Sequencing Market Outlook: Product
    • 5.3.1. Introduction / Key Findings
    • 5.3.2. Historical Market Size (US$ Mn) and Volume (Units) Analysis, By Product, 2019-2024
    • 5.3.3. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
      • 5.3.3.1. Instruments
      • 5.3.3.2. Consumables
      • 5.3.3.3. Software & Services
    • 5.3.4. Market Attractiveness Analysis: Product
  • 5.4. Global Whole Exome Sequencing Market Outlook: Application
    • 5.4.1. Introduction / Key Findings
    • 5.4.2. Historical Market Size (US$ Mn), By Application, 2019-2024
    • 5.4.3. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
      • 5.4.3.1. Drug Discovery & Development
      • 5.4.3.2. Clinical Diagnostics
      • 5.4.3.3. Personalized Medicines
      • 5.4.3.4. Others
    • 5.4.4. Market Attractiveness Analysis: Application
  • 5.5. Global Whole Exome Sequencing Market Outlook: Technology
    • 5.5.1. Introduction / Key Findings
    • 5.5.2. Historical Market Size (US$ Mn), By Technology, 2019-2024
    • 5.5.3. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
      • 5.5.3.1. ION Semiconductor Sequencing
      • 5.5.3.2. Sequencing by Synthesis
      • 5.5.3.3. Others
    • 5.5.4. Market Attractiveness Analysis: Technology
  • 5.6. Global Whole Exome Sequencing Market Outlook: End User
    • 5.6.1. Introduction / Key Findings
    • 5.6.2. Historical Market Size (US$ Mn), By End User, 2019-2024
    • 5.6.3. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
      • 5.6.3.1. Hospitals & Diagnostic Laboratories
      • 5.6.3.2. Pharma & Biotech Companies
      • 5.6.3.3. Contract Research Organizations (CROs)
      • 5.6.3.4. Academic and Research Institutions
      • 5.6.3.5. Others
    • 5.6.4. Market Attractiveness Analysis: End User

6. Global Whole Exome Sequencing Market Outlook: Region

  • 6.1. Key Highlights
  • 6.2. Historical Market Size (US$ Mn) Analysis, By Region, 2019-2024
  • 6.3. Market Size (US$ Mn) Analysis and Forecast, By Region, 2025-2032
    • 6.3.1. North America
    • 6.3.2. Europe
    • 6.3.3. East Asia
    • 6.3.4. South Asia and Oceania
    • 6.3.5. Latin America
    • 6.3.6. Middle East & Africa
  • 6.4. Market Attractiveness Analysis: Region

7. North America Whole Exome Sequencing Market Outlook

  • 7.1. Key Highlights
  • 7.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 7.2.1. By Country
    • 7.2.2. By Product
    • 7.2.3. By Application
    • 7.2.4. By Technology
    • 7.2.5. By End User
  • 7.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 7.3.1. U.S.
    • 7.3.2. Canada
  • 7.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 7.4.1. Instruments
    • 7.4.2. Consumables
    • 7.4.3. Software & Services
  • 7.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 7.5.1. Drug Discovery & Development
    • 7.5.2. Clinical Diagnostics
    • 7.5.3. Personalized Medicines
    • 7.5.4. Others
  • 7.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 7.6.1. ION Semiconductor Sequencing
    • 7.6.2. Sequencing by Synthesis
    • 7.6.3. Others
  • 7.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 7.7.1. Hospitals & Diagnostic Laboratories
    • 7.7.2. Pharma & Biotech Companies
    • 7.7.3. Contract Research Organizations (CROs)
    • 7.7.4. Academic and Research Institutions
    • 7.7.5. Others
  • 7.8. Market Attractiveness Analysis

8. Europe Whole Exome Sequencing Market Outlook

  • 8.1. Key Highlights
  • 8.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 8.2.1. By Country
    • 8.2.2. By Product
    • 8.2.3. By Application
    • 8.2.4. By Technology
    • 8.2.5. By End User
  • 8.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 8.3.1. Germany
    • 8.3.2. France
    • 8.3.3. U.K.
    • 8.3.4. Italy
    • 8.3.5. Spain
    • 8.3.6. Russia
    • 8.3.7. Turkey
    • 8.3.8. Rest of Europe
  • 8.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 8.4.1. Instruments
    • 8.4.2. Consumables
    • 8.4.3. Software & Services
  • 8.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 8.5.1. Drug Discovery & Development
    • 8.5.2. Clinical Diagnostics
    • 8.5.3. Personalized Medicines
    • 8.5.4. Others
  • 8.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 8.6.1. ION Semiconductor Sequencing
    • 8.6.2. Sequencing by Synthesis
    • 8.6.3. Others
  • 8.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 8.7.1. Hospitals & Diagnostic Laboratories
    • 8.7.2. Pharma & Biotech Companies
    • 8.7.3. Contract Research Organizations (CROs)
    • 8.7.4. Academic and Research Institutions
    • 8.7.5. Others
  • 8.8. Market Attractiveness Analysis

9. East Asia Whole Exome Sequencing Market Outlook

  • 9.1. Key Highlights
  • 9.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 9.2.1. By Country
    • 9.2.2. By Product
    • 9.2.3. By Application
    • 9.2.4. By Technology
    • 9.2.5. By End User
  • 9.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 9.3.1. China
    • 9.3.2. Japan
    • 9.3.3. South Korea
  • 9.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 9.4.1. Instruments
    • 9.4.2. Consumables
    • 9.4.3. Software & Services
  • 9.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 9.5.1. Drug Discovery & Development
    • 9.5.2. Clinical Diagnostics
    • 9.5.3. Personalized Medicines
    • 9.5.4. Others
  • 9.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 9.6.1. ION Semiconductor Sequencing
    • 9.6.2. Sequencing by Synthesis
    • 9.6.3. Others
  • 9.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 9.7.1. Hospitals & Diagnostic Laboratories
    • 9.7.2. Pharma & Biotech Companies
    • 9.7.3. Contract Research Organizations (CROs)
    • 9.7.4. Academic and Research Institutions
    • 9.7.5. Others
  • 9.8. Market Attractiveness Analysis

10. South Asia & Oceania Whole Exome Sequencing Market Outlook

  • 10.1. Key Highlights
  • 10.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 10.2.1. By Country
    • 10.2.2. By Product
    • 10.2.3. By Application
    • 10.2.4. By Technology
    • 10.2.5. By End User
  • 10.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 10.3.1. India
    • 10.3.2. Southeast Asia
    • 10.3.3. ANZ
    • 10.3.4. Rest of South Asia & Oceania
  • 10.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 10.4.1. Instruments
    • 10.4.2. Consumables
    • 10.4.3. Software & Services
  • 10.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 10.5.1. Drug Discovery & Development
    • 10.5.2. Clinical Diagnostics
    • 10.5.3. Personalized Medicines
    • 10.5.4. Others
  • 10.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 10.6.1. ION Semiconductor Sequencing
    • 10.6.2. Sequencing by Synthesis
    • 10.6.3. Others
  • 10.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 10.7.1. Hospitals & Diagnostic Laboratories
    • 10.7.2. Pharma & Biotech Companies
    • 10.7.3. Contract Research Organizations (CROs)
    • 10.7.4. Academic and Research Institutions
    • 10.7.5. Others
  • 10.8. Market Attractiveness Analysis

11. Latin America Whole Exome Sequencing Market Outlook

  • 11.1. Key Highlights
  • 11.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 11.2.1. By Country
    • 11.2.2. By Product
    • 11.2.3. By Application
    • 11.2.4. By Technology
    • 11.2.5. By End User
  • 11.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 11.3.1. Brazil
    • 11.3.2. Mexico
    • 11.3.3. Rest of Latin America
  • 11.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 11.4.1. Instruments
    • 11.4.2. Consumables
    • 11.4.3. Software & Services
  • 11.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 11.5.1. Drug Discovery & Development
    • 11.5.2. Clinical Diagnostics
    • 11.5.3. Personalized Medicines
    • 11.5.4. Others
  • 11.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 11.6.1. ION Semiconductor Sequencing
    • 11.6.2. Sequencing by Synthesis
    • 11.6.3. Others
  • 11.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 11.7.1. Hospitals & Diagnostic Laboratories
    • 11.7.2. Pharma & Biotech Companies
    • 11.7.3. Contract Research Organizations (CROs)
    • 11.7.4. Academic and Research Institutions
    • 11.7.5. Others
  • 11.8. Market Attractiveness Analysis

12. Middle East & Africa Whole Exome Sequencing Market Outlook

  • 12.1. Key Highlights
  • 12.2. Historical Market Size (US$ Mn) Analysis, By Market, 2019-2024
    • 12.2.1. By Country
    • 12.2.2. By Product
    • 12.2.3. By Application
    • 12.2.4. By Technology
    • 12.2.5. By End User
  • 12.3. Market Size (US$ Mn) Analysis and Forecast, By Country, 2025-2032
    • 12.3.1. GCC Countries
    • 12.3.2. Egypt
    • 12.3.3. South Africa
    • 12.3.4. Northern Africa
    • 12.3.5. Rest of Middle East & Africa
  • 12.4. Market Size (US$ Mn) and Volume (Units) Analysis and Forecast, By Product, 2025-2032
    • 12.4.1. Instruments
    • 12.4.2. Consumables
    • 12.4.3. Software & Services
  • 12.5. Market Size (US$ Mn) Analysis and Forecast, By Application, 2025-2032
    • 12.5.1. Drug Discovery & Development
    • 12.5.2. Clinical Diagnostics
    • 12.5.3. Personalized Medicines
    • 12.5.4. Others
  • 12.6. Market Size (US$ Mn) Analysis and Forecast, By Technology, 2025-2032
    • 12.6.1. ION Semiconductor Sequencing
    • 12.6.2. Sequencing by Synthesis
    • 12.6.3. Others
  • 12.7. Market Size (US$ Mn) Analysis and Forecast, By End User, 2025-2032
    • 12.7.1. Hospitals & Diagnostic Laboratories
    • 12.7.2. Pharma & Biotech Companies
    • 12.7.3. Contract Research Organizations (CROs)
    • 12.7.4. Academic and Research Institutions
    • 12.7.5. Others
  • 12.8. Market Attractiveness Analysis

13. Competition Landscape

  • 13.1. Market Share Analysis, 2025
  • 13.2. Market Structure
    • 13.2.1. Competition Intensity Mapping By Market
    • 13.2.2. Competition Dashboard
  • 13.3. Company Profiles (Details - Overview, Financials, Strategy, Recent Developments)
    • 13.3.1. CD Genomics
      • 13.3.1.1. Overview
      • 13.3.1.2. Segments and Products
      • 13.3.1.3. Key Financials
      • 13.3.1.4. Market Developments
      • 13.3.1.5. Market Strategy
    • 13.3.2. Eurofins Genomics
    • 13.3.3. GENEWIZ (Azenta Life Sciences)
    • 13.3.4. Illumina, Inc.
    • 13.3.5. Integrated DNA Technologies, Inc.
    • 13.3.6. Blueprint Genetics Oy
    • 13.3.7. Caris Life Sciences
    • 13.3.8. MedGenome
    • 13.3.9. Psomagen
    • 13.3.10. 3billion, Inc.
    • 13.3.11. BGI
    • 13.3.12. Mapmygenome
    • 13.3.13. Almac Group
    • 13.3.14. CeGaT GmbH
    • 13.3.15. Novogene Co., Ltd
    • 13.3.16. ONEOMICS
    • 13.3.17. Celemics, Inc.
    • 13.3.18. Dreamgenics, S.L.
    • 13.3.19. Gene by Gene, Ltd
    • 13.3.20. VERITAS INTERCONTINENTAL
    • 13.3.21. Laboratory Corporation of America(R) Holdings
    • 13.3.22. Revvity
    • 13.3.23. Thermo Fisher Scientific Inc.

14. Appendix

  • 14.1. Research Methodology
  • 14.2. Research Assumptions
  • 14.3. Acronyms and Abbreviations